Research and Development

Other Research Areas

CCO has ongoing research and development involvement across a number of areas of activity, often in conjunction with other hospitals or industry:

Area of Research

Intensity Modulated Radiotherapy (IMRT) - (in conjunction with Nucletron Ltd and Tubingen University)

High Resolution Radiotherapy (HRRT) - (in conjunction with Elekta Ltd and MRC Ltd)

Brain Cancer Research - (in conjunction with Walton Centre for Neurology and Neurosurgery, Liverpool)

Magnetic-resonance (MR) based planning - (in conjunction with Royal Marsden Hospital, London)

Proton Beam Therapy - (in conjunction with St Paul's Eye Hospital, Liverpool)

Radionuclide Production - (in conjunction with Christie Hospital, Manchester)

MR Based Planning - (in conjunction with the University of Manchester)

The laboratory research programme can be seen by referring to the CCRT website.

Research Expenditure

The clinical trials programme is funded primarily from income from the NHS research fund allocation and research trials subvention monies, from accrued income associated with commercial trials, and from income provided by the national trials organisations.

The other research areas are funded primarily by a mixture of CCO Research Endowment and other charitable research funding.

The following table is taken from the 1999/2000 R&D report and indicates the planned expenditure for each research activity area. Column B indicates the money from NHS R&D funds, and column G indicates funding from other sources. This table excludes CCO input to the CCRT laboratory research programme.

Research Types

Clinical Trials

Other Research